Dallah Healthcare Company (4004.SE) announced the development of the usage of company’s IPO proceeds, where the main highlights included the completion of 32% of Dallah Namar Hospital, as of end of June 2016. The project is expected to commence the first phase of operations in 3Q17, including 150 beds and 100 clinics, where the project’s total planned capacity will include 400 beds and 200 clinics. The project consumed 67% of the IPO proceeds to date. (Company disclosure)   Dallah Healthcare: SAR89.66 as of 14 July 2016, Rating: Buy, FV: SAR90.00 per share, MCap: USD1,411mn, DALLAH AB / 4004.SE